Nova Steroid Pharma Co.,Ltd
Benzocaine Powder For Local Anesthetics CAS:94-09-7

Benzocaine Powder For Local Anesthetics CAS:94-09-7

Benzocaine, chemically known as ethyl 4-aminobenzoate, is an ester-type local anesthetic first synthesized in the late 19th century. Unlike amide anesthetics (e.g., lidocaine), benzocaine’s ester linkage makes it hydrolyzable by plasma esterases, leading to a shorter metabolic pathway.

Send Inquiry
Description

    Introduction to Benzocaine

    Benzocaine, chemically known as ethyl 4-aminobenzoate, is an ester-type local anesthetic first synthesized in the late 19th century. Unlike amide anesthetics (e.g., lidocaine), benzocaine's ester linkage makes it hydrolyzable by plasma esterases, leading to a shorter metabolic pathway. It appears as a white, crystalline powder with a slight aromatic odor and is sparingly soluble in water but highly soluble in alcohols and lipids, enabling its use in diverse formulations.

maxresdefault

Key Features

    ●Mechanism of Action: Benzocaine blocks voltage-gated sodium channels, inhibiting nerve impulse propagation. It preferentially binds to activated channels, stabilizing neuronal membranes.

    ●Onset and Duration: Rapid onset (1–2 minutes) but shorter duration (15–30 minutes) compared to injectable anesthetics, ideal for transient procedures.

    ●pH Sensitivity: Effective in acidic environments, often formulated with low-pH vehicles to enhance penetration.

    ●Stability: Degrades under alkaline conditions or UV exposure, requiring opaque, airtight storage.

Applications

    ●Medical:

    ○Topical Relief: Creams (5–20%) for burns, insect bites, or minor cuts.

    ○Procedural Use: Endoscopy (throat sprays) or dermatological treatments (cryotherapy).

    ●Dental: Gel formulations (10–20%) for gingival pain or denture adjustments.

    ●Veterinary: Aquaculture (sedating fish) and pet care (ear infections).

    ●OTC Products: Throat lozenges (3–5 mg/dose) and hemorrhoid creams.

Benefits Over Alternatives

    ●Non-Invasive: Eliminates needle use, reducing patient anxiety.

    ●Low Systemic Absorption: Minimizes toxicity risks when applied correctly.

    ●Cost-Effective: Synthesized from inexpensive precursors (PABA and ethanol).

    ●Allergen Profile: Rare hypersensitivity compared to amides, though cross-reactivity with ester drugs exists.

Dosage and Administration

    ●Concentration Guidelines:

    ○Skin Preparations: 5–20% in creams or ointments.

    ○Mucosal Use: 10–20% gels for oral or rectal mucosa.

    ○Sprays/Lozenges: 3–5% solutions, limited to 200 mg per dose.

    ●Pediatric Caution: Avoid in infants <2 years due to methemoglobinemia risk.

Metabolic Cycle and Half-Life

    ●Absorption: Poor systemic uptake through intact skin; enhanced via mucous membranes.

    ●Metabolism: Hydrolyzed by plasma cholinesterases to PABA and ethanol, excreted renally.

    ●Half-Life: ~1–2 hours in adults; prolonged in hepatic impairment or esterase deficiency.

Pregnancy, Toxicity, and Contraindications (PTC)

    ●Pregnancy: FDA Category C (risk not ruled out; use if benefits outweigh risks).

    ●Toxicity:

    ○Methemoglobinemia: Cyanosis, dyspnea; treat with methylene blue (1–2 mg/kg IV).

    ○Overdose: CNS depression; manage with supportive care.

    ●Contraindications: Hypersensitivity to esters, congenital methemoglobinemia, or concurrent sulfonamide use (PABA antagonism).

Regulatory and Safety Considerations

    ●FDA Warnings: Restricted in teething products (2018) due to infant fatalities.

    ●Environmental Impact: Low ecotoxicity but requires proper disposal to avoid aquatic contamination.

 Half-Life and Dosing Frequency

    With a 4–6 hour half-life, Dianabol requires multiple daily doses to maintain stable blood levels. Twice-daily dosing (e.g., 10mg at 8 AM and 8 PM) mitigates peaks and troughs, optimizing anabolic continuity.

Innovations and Future Directions

    ●Nanoformulations: Liposomal encapsulation to prolong duration.

    ●Combination Therapies: Synergy with menthol or antipyrine for enhanced efficacy.

Clinical Data

Trade Names

Lyrica,3-isobutyl GABA, (S)-3-isobutyl-γ-aminobutyric acid

CAS

94-09-7

Molar mass

165.189

Formula

C9H11NO2

Purity

Above 98%

Apprarance

White Crystalline Powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-19128233885

   

QQ20240306150406                product-368-486                 product-521-245

 

Conclusion

  Benzocaine remains a versatile, cost-efficient anesthetic with niche applications in medicine, dentistry, and veterinary care. While its safety profile is favorable, adherence to dosing guidelines and awareness of toxicity risks are critical. Ongoing research aims to expand its utility through advanced delivery systems.

Hot Tags: benzocaine powder for local anesthetics cas:94-09-7, China benzocaine powder for local anesthetics cas:94-09-7 manufacturers, suppliers, factory, Adjust fat distribution of Testosterone Cypionate, Bodybuilding body function Methyltestosterone, Cialis Treating Erectile Dysfunction, Stanolone, Steroid Raw Powders Injectables, Toremifene Citrate

Inquiry
goTop

(0/10)

clearall